BASICS
DESCRIPTION
• Involuntary closure of both eyelids (blepharospasm) or muscles innervated by facial nerve unilaterally (hemifacial spasm):
– Blepharospasm:
– Essential (without associated disease)
– Blepharospasm-oromandibular dystonia or Meige syndrome (dystonia of face, jaw, and neck)
– Secondary – due to ocular irritation
– Hemifacial spasm
• System(s) affected: Nervous; musculoskeletal
EPIDEMIOLOGY
• Predominant age: Middle age (40–60 years)
• Predominant sex: Female > Male (2–4:1)
Incidence
2000 cases of blepharospasm diagnosed annually in the USA (1)
Prevalence
• 1.6–13.3/100,000 for blepharospasm
• 7.4–14.5/100,000 for hemifacial spasm
RISK FACTORS
• Blepharospasm:
– Head or facial trauma
– Specific eye disease, e.g., blepharitis and keratoconjunctivitis
– Family history of dystonia or tremor (2)
– Cigarette smoking was considered a negative risk factor earlier, but not in recent studies (3,4).
• Hemifacial spasm has no known risk factors.
Genetics
• Most sporadic, yet familial variety with autosomal dominance and incomplete penetrance in blepharospasm
• No genetic relationships known with hemifacial spasm
PATHOPHYSIOLOGY
• Blepharospasm:
– Two opposing muscle groups, protractors (orbicularis, corrugator, and procerus) and retractors (levator palpebra superioris and frontalis), fire at the same time.
– Sensitization of the trigeminal system via photophobia (2)
– Theory of ion channelopathy (5)
• Hemifacial spasm:
– Ephaptic transmission
ETIOLOGY
• Hemifacial spasm:
– Vascular compression of the facial nerve by an abnormal artery
– Rarely tumors of the posterior fossa compressing the facial nerve (6)
COMMONLY ASSOCIATED CONDITIONS
• Blepharospasm:
– Dry eyes
– Movement disorders, strokes
DIAGNOSIS
HISTORY
• Blepharospasm (1)[C]
– Increase blinking progresses to involuntary spasms of eyelids, initially unilateral:
Increases in severity and frequency
Often has ocular irritation
• History of drug use with tardive dyskinesia
• Hemifacial spasm:
– Involuntary eye closure that progresses over months to years to other facial muscles on the same side
PHYSICAL EXAM
• Blepharospasm:
– Nonvolitional contraction of multiple muscles (both protractors and retractors), not just orbicularis
– Careful exclusion of ocular causes
– Observation for other tics which are more brief, may involve winking
• Hemifacial spasm:
– Synchronous spasm of multiple facial muscle ipsilaterally
DIAGNOSTIC TESTS & INTERPRETATION
Lab
• MRI brain
• MRI/MRA brain with attention to the posterior fossa
Pathological Findings
Abnormal blood vessels: aneurysms, dolichoectasia, etc.
DIFFERENTIAL DIAGNOSIS
• Blepharospasm:
– Ocular myokymia
– Associated with lesions of brainstem and basal ganglia (Parkinson disease, Huntington disease, Wilson disease, Creutzfeldt–Jakob disease, progressive external ophthalmoplegia)
– Reflex (due to temporoparietal strokes)
– Ocular (irritative ocular disease, e.g., entropion)
– Tardive dyskinesia
– Facial tics (Tourette syndrome)
– Functional
– Focal seizures
• Hemifacial spasm:
– Tardive dyskinesia
– Myokymia
– Tics
– Dystonia
– Functional
TREATMENT
MEDICATION
First Line
• Treat underlying etiology in secondary etiologies.
• Botulinum toxin injection (7)[B], (8)[A]:
– Every 3–4 months
Second Line
• Oral medications (carbamazepine, anticholinergics, baclofen, clonazepam, haloperidol):
– Often sedating and not helpful
ADDITIONAL TREATMENT
Issues for Referral
Socially upsetting to sight impairment
SURGERY/OTHER PROCEDURES
• Blepharospasm:
– Orbicularis myectomy
– Differential section of the facial nerve
– Superior cervical ganglion block
• Hemifacial spasm:
– Microvascular decompression
ONGOING CARE
FOLLOW-UP RECOMMENDATIONS
• 1 month after botulinum injections
• If well reinjection every 3 months or longer
PATIENT EDUCATION
• Benign Essential Blepharospasm Research Foundation found to be helpful and other therapies
• Patient and family fact sheet (9)
• Reduce coffee intake
PROGNOSIS
90% improve with botulinum injections
COMPLICATIONS
With microvascular surgery can have facial weakness and hearing loss.
REFERENCES
1. Ben Simon GJ, McCann JD. Benign essential blepharospasm. Int Ophthalmol Clin 2005;45:45–79.
2. Hallett M, Evionger C, Jankovic J, Stacy M. Update on blepharospasm. Report from the BEBRF International Workshop. Neurology 2008;71:1275–1282.
3. Defazio G, Martino D, Abbruzzese G, et al. Influence of coffee drinking and cigarette smoking on the risk of primary late onset blepharospasom: evidence from a multicentre case control study. J Neurol Neurosurg Psychiatry. 2007;78:877–879.
4. Hall TA, McGwin G, Searcey K, et al. Benign essential blepharospasm: risk factors with reference to hemifacial spasm. J Neuroophthalmol 2005;25:280–285.
5. Leon-Sarmiento FE, Bayona-Prieto J, Gomez J. Neurophysiology of blepharospasm and multiple system atrophy: clues to its pathophysiology. Parkinsonism and Related Disorders 2005;11:199–201.
6. Han I-B, Chang JH, Chang JW, et al. Unusual causes and presentations of hemifacial spasm. Neurosurgery 2009;65:130–137.
7. Quagliato EMAB, Carelli EF, Viana MA. Prospective, randomized, double-blind study, comparing botulinum toxins type A Botox and Prosigne for blepharospasm and hemifacial spasm treatment. Clin Neuropharmacol 2010;33:27–31.
8. Costa J, Espirito-Santo C, Borges A, et al. Botulinum toxin type A therapy for blepharospasm (Review). Cochrane Database Syst Rev 2005;1:1–11.
9. Whitney CM. Benign essential blepharospasm The Neurologist 2005;11:193–194.